Evidence
Evidence is the permission system.
What is established. What is operating. What is being tested. What remains to be shown.
Status
Every part of the system carries its current status.
Published
Research Brief 01, August 2026: across thirteen school systems, every one requires capacities such as self-regulation, attention and social repair; in none did we identify an operating architecture that combines delivery, fidelity and validated measurement.
Operating
The Method at published pricing; the 28-point delivery standard scored every session; the first certification cohort; the development record at MVP scope: capture, tracking, family view, role-specific next actions.
In validation
The Capacity Index and per-child trajectory; institutional reporting; the research architecture across construct validity, sensitivity to change, attribution, decision utility and generalisability. An Innosuisse Innovation Project route is selected with a Swiss research partner; scope in development.
To be established independently
Efficacy claims, transfer across educators and schools, and measurement usable beyond Embreier's own delivery. Validation is owned or independently verified by the research partner; rater bias, inter-rater reliability and blinded scoring sit in the design.
The gates
We monetise each layer when its evidence is in.
A + B
Validity
Construct validity and sensitivity to change unlock Outcomes Intelligence.
C
Attribution
What preceded and followed change unlocks efficacy claims.
E1
Transfer
Across educators, schools and languages unlocks school groups.
E2
Generalisability
Beyond Embreier delivery unlocks shared infrastructure.
If the measurement stays specific to Embreier delivery, the company remains a Method, Certification and Outcomes business within its own delivery, which is the whole of the underwritten case.
Grants are treated as offsets when secured; the company funds the validation case without assuming them. Research partners are named only once agreements are executed.
Confidential. This page does not constitute an offer of securities. Market sizes and statuses are management statements as at September 2026 and are not guidance. Figures are as published by their sources at the date of access.